Decks cleared for import of Bharat Biotech's Covaxin, Russia's Sputnik V into Brazil

National Health Surveillance Agency of Brazil-Anvisa had earlier denied permission to import Covaxin after authorities found that the Indian plant in which the jab was being made did not meet the Good Manufacturing Practice (GMP) requirements.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2T1NjtS
via IFTTT